Rare diseases
Investigational molecules
Locations
191 Wood Lane, W12 7FP, United Kingdom
Autolus Limited focuses on B-cell acute lymphoblastic leukemia and aggressive mature B-cell non-Hodgkin lymphoma, with research centered on CD19-directed CAR T-cell therapy for relapsed or refractory disease in both adult and pediatric populations.
Its oncology portfolio also includes follow-up studies in patients previously treated with genetically modified autologous T cells.
Autolus Limited runs clinical trials in conditions such as Acute lymphocytic leukaemia, Systemic lupus erythematosus, Non-Hodgkin's lymphoma, Lupus nephritis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
SpainSpain
GreeceSpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
